The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues

Begoña Galocha, Ann Hill, Barbara C. Barnett, Aidan Dolan, Alejandra Raimondi, Richard F. Cook, Joseph Brunner, Duncan J. McGeoch, Hidde L. Ploegh

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

The herpes simplex virus (HSV) immediate early protein ICP47 inhibits the transporter associated with antigen processing (TAP)-dependent peptide translocation. As a consequence, empty major histocompatibility complex (MHC) class I molecules are retained in the endoplasmic reticulum and recognition of HSV-infected cells by cytotoxic T lymphocytes is abolished. We chemically synthesized full-length ICP47 (sICP47) and show that sICP47 inhibits TAP- dependent peptide translocation in human cells. Its biological activity is indistinguishable from that of recombinant ICP47 (rICP47). By using synthetic peptides, we mapped the core sequence of ICP47 minimally required for TAP inhibition to residues 2-35. This segment is located within the region of the molecule conserved between ICP47 from HSV-1 and HSV-2. Through alanine scanning substitution we identified three segments within this region that are critical for the ability to inhibit TAP function. The interaction of ICP47 with TAP is unlikely to mimic precisely that of the transported peptides, as deduced from differential labeling of the TAP1 and TAP2 subunits using sICP47 fragments with chemical cross-linkers.

Original languageEnglish (US)
Pages (from-to)1565-1572
Number of pages8
JournalJournal of Experimental Medicine
Volume185
Issue number9
DOIs
StatePublished - May 5 1997

Fingerprint

trypsinogen activation peptide
Simplexvirus
Major Histocompatibility Complex
Catalytic Domain
Immediate-Early Proteins
Peptides
Human Herpesvirus 2
Human Herpesvirus 1
Cytotoxic T-Lymphocytes
Endoplasmic Reticulum
Alanine
peptide permease
transporter associated with antigen processing (TAP)

ASJC Scopus subject areas

  • Immunology

Cite this

The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. / Galocha, Begoña; Hill, Ann; Barnett, Barbara C.; Dolan, Aidan; Raimondi, Alejandra; Cook, Richard F.; Brunner, Joseph; McGeoch, Duncan J.; Ploegh, Hidde L.

In: Journal of Experimental Medicine, Vol. 185, No. 9, 05.05.1997, p. 1565-1572.

Research output: Contribution to journalArticle

Galocha, Begoña ; Hill, Ann ; Barnett, Barbara C. ; Dolan, Aidan ; Raimondi, Alejandra ; Cook, Richard F. ; Brunner, Joseph ; McGeoch, Duncan J. ; Ploegh, Hidde L. / The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues. In: Journal of Experimental Medicine. 1997 ; Vol. 185, No. 9. pp. 1565-1572.
@article{626c81b60d0041719e7293bdaabc5871,
title = "The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues",
abstract = "The herpes simplex virus (HSV) immediate early protein ICP47 inhibits the transporter associated with antigen processing (TAP)-dependent peptide translocation. As a consequence, empty major histocompatibility complex (MHC) class I molecules are retained in the endoplasmic reticulum and recognition of HSV-infected cells by cytotoxic T lymphocytes is abolished. We chemically synthesized full-length ICP47 (sICP47) and show that sICP47 inhibits TAP- dependent peptide translocation in human cells. Its biological activity is indistinguishable from that of recombinant ICP47 (rICP47). By using synthetic peptides, we mapped the core sequence of ICP47 minimally required for TAP inhibition to residues 2-35. This segment is located within the region of the molecule conserved between ICP47 from HSV-1 and HSV-2. Through alanine scanning substitution we identified three segments within this region that are critical for the ability to inhibit TAP function. The interaction of ICP47 with TAP is unlikely to mimic precisely that of the transported peptides, as deduced from differential labeling of the TAP1 and TAP2 subunits using sICP47 fragments with chemical cross-linkers.",
author = "Bego{\~n}a Galocha and Ann Hill and Barnett, {Barbara C.} and Aidan Dolan and Alejandra Raimondi and Cook, {Richard F.} and Joseph Brunner and McGeoch, {Duncan J.} and Ploegh, {Hidde L.}",
year = "1997",
month = "5",
day = "5",
doi = "10.1084/jem.185.9.1565",
language = "English (US)",
volume = "185",
pages = "1565--1572",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "9",

}

TY - JOUR

T1 - The active site of ICP47, a herpes simplex virus-encoded inhibitor of the major histocompatibility complex (MHC)-encoded peptide transporter associated with antigen processing (TAP), maps to the NH2-terminal 35 residues

AU - Galocha, Begoña

AU - Hill, Ann

AU - Barnett, Barbara C.

AU - Dolan, Aidan

AU - Raimondi, Alejandra

AU - Cook, Richard F.

AU - Brunner, Joseph

AU - McGeoch, Duncan J.

AU - Ploegh, Hidde L.

PY - 1997/5/5

Y1 - 1997/5/5

N2 - The herpes simplex virus (HSV) immediate early protein ICP47 inhibits the transporter associated with antigen processing (TAP)-dependent peptide translocation. As a consequence, empty major histocompatibility complex (MHC) class I molecules are retained in the endoplasmic reticulum and recognition of HSV-infected cells by cytotoxic T lymphocytes is abolished. We chemically synthesized full-length ICP47 (sICP47) and show that sICP47 inhibits TAP- dependent peptide translocation in human cells. Its biological activity is indistinguishable from that of recombinant ICP47 (rICP47). By using synthetic peptides, we mapped the core sequence of ICP47 minimally required for TAP inhibition to residues 2-35. This segment is located within the region of the molecule conserved between ICP47 from HSV-1 and HSV-2. Through alanine scanning substitution we identified three segments within this region that are critical for the ability to inhibit TAP function. The interaction of ICP47 with TAP is unlikely to mimic precisely that of the transported peptides, as deduced from differential labeling of the TAP1 and TAP2 subunits using sICP47 fragments with chemical cross-linkers.

AB - The herpes simplex virus (HSV) immediate early protein ICP47 inhibits the transporter associated with antigen processing (TAP)-dependent peptide translocation. As a consequence, empty major histocompatibility complex (MHC) class I molecules are retained in the endoplasmic reticulum and recognition of HSV-infected cells by cytotoxic T lymphocytes is abolished. We chemically synthesized full-length ICP47 (sICP47) and show that sICP47 inhibits TAP- dependent peptide translocation in human cells. Its biological activity is indistinguishable from that of recombinant ICP47 (rICP47). By using synthetic peptides, we mapped the core sequence of ICP47 minimally required for TAP inhibition to residues 2-35. This segment is located within the region of the molecule conserved between ICP47 from HSV-1 and HSV-2. Through alanine scanning substitution we identified three segments within this region that are critical for the ability to inhibit TAP function. The interaction of ICP47 with TAP is unlikely to mimic precisely that of the transported peptides, as deduced from differential labeling of the TAP1 and TAP2 subunits using sICP47 fragments with chemical cross-linkers.

UR - http://www.scopus.com/inward/record.url?scp=0030922680&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030922680&partnerID=8YFLogxK

U2 - 10.1084/jem.185.9.1565

DO - 10.1084/jem.185.9.1565

M3 - Article

VL - 185

SP - 1565

EP - 1572

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 9

ER -